How to evaluate the patient with a suspected mast cell disorder and how/when to manage symptoms

Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):55-63. doi: 10.1182/hematology.2022000366.

Abstract

Mast cell disorders include mastocytosis and mast cell activation syndromes. Mastocytosis is a rare clonal disorder of the mast cell, driven by KIT D816V mutation in most cases. Mastocytosis is diagnosed and classified according to World Health Organization criteria. Mast cell activation syndromes encompass a diverse group of disorders and may have clonal or nonclonal etiologies. Hematologists may be consulted to assist in the diagnostic workup and/or management of mast cell disorders. A consult to the hematologist for mast cell disorders may provoke anxiety due to the rare nature of these diseases and the management of nonhematologic mast cell activation symptoms. This article presents recommendations on how to approach the diagnosis and management of patients referred for common clinical scenarios.

MeSH terms

  • Humans
  • Mast Cell Activation Syndrome*
  • Mast Cells
  • Mastocytosis* / diagnosis
  • Mastocytosis* / genetics
  • Mastocytosis* / therapy
  • Mastocytosis, Systemic* / diagnosis
  • Mastocytosis, Systemic* / genetics
  • Mastocytosis, Systemic* / therapy
  • Mutation
  • Proto-Oncogene Proteins c-kit / genetics

Substances

  • Proto-Oncogene Proteins c-kit